Ardent Health Partners, LLC (NYSE:ARDT) Receives $21.18 Average PT from Brokerages

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have been given a consensus recommendation of “Buy” by the twelve research firms that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $21.18.

A number of brokerages have recently commented on ARDT. Stephens restated an “overweight” rating and issued a $22.00 target price on shares of Ardent Health Partners in a research note on Wednesday. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Truist Financial dropped their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Morgan Stanley decreased their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Finally, Royal Bank of Canada dropped their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th.

Ardent Health Partners Stock Up 0.3 %

ARDT opened at $13.15 on Tuesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a 12-month low of $12.87 and a 12-month high of $20.72. The firm has a 50 day moving average of $14.43 and a two-hundred day moving average of $16.28.

Ardent Health Partners (NYSE:ARDT) last issued its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. On average, equities research analysts expect that Ardent Health Partners will post 1.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Ventas Inc. acquired a new stake in Ardent Health Partners in the 4th quarter worth about $159,570,000. Wellington Management Group LLP purchased a new position in shares of Ardent Health Partners in the third quarter valued at approximately $28,724,000. Point72 Asset Management L.P. acquired a new stake in shares of Ardent Health Partners in the third quarter worth approximately $27,428,000. Goldentree Asset Management LP purchased a new stake in shares of Ardent Health Partners during the third quarter worth approximately $22,897,000. Finally, Franklin Resources Inc. acquired a new position in Ardent Health Partners in the 3rd quarter valued at $15,839,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.